Jasper Therapeutics Inc.

4.00
-0.23 (-5.44%)
At close: Apr 03, 2025, 3:59 PM
4.01
0.09%
After-hours: Apr 03, 2025, 04:50 PM EDT

Jasper Therapeutics Statistics

Share Statistics

Jasper Therapeutics has 15.02M shares outstanding. The number of shares has increased by -0.42% in one year.

Shares Outstanding 15.02M
Shares Change (YoY) -0.42%
Shares Change (QoQ) 0.14%
Owned by Institutions (%) 68.35%
Shares Floating 11.88M
Failed to Deliver (FTD) Shares 30
FTD / Avg. Volume 0.01%

Short Selling Information

The latest short interest is 3.22M, so 21.43% of the outstanding shares have been sold short.

Short Interest 3.22M
Short % of Shares Out 21.43%
Short % of Float 28.62%
Short Ratio (days to cover) 3.88

Valuation Ratios

The PE ratio is 0 and the forward PE ratio is -1.15. Jasper Therapeutics's PEG ratio is 0.

PE Ratio 0
Forward PE -1.15
PS Ratio 0
Forward PS 0.4
PB Ratio 5.06
P/FCF Ratio -4.94
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Jasper Therapeutics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.98, with a Debt / Equity ratio of 0.03.

Current Ratio 4.98
Quick Ratio 4.98
Debt / Equity 0.03
Debt / EBITDA -0.02
Debt / FCF -0.03
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $0
Employee Count 64
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -84.35% in the last 52 weeks. The beta is 2.24, so Jasper Therapeutics's price volatility has been higher than the market average.

Beta 2.24
52-Week Price Change -84.35%
50-Day Moving Average 5.59
200-Day Moving Average 16.2
Relative Strength Index (RSI) 29.07
Average Volume (20 Days) 551.1K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -76.24M
Net Income 0
EBITDA -76.24M
EBIT n/a
Earnings Per Share (EPS) -4.89
Full Income Statement

Balance Sheet

The company has 71.64M in cash and 1.81M in debt, giving a net cash position of 69.82M.

Cash & Cash Equivalents 71.64M
Total Debt 1.81M
Net Cash 69.82M
Retained Earnings -240.87M
Total Assets 79.9M
Working Capital 60.57M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -62.6M and capital expenditures -552K, giving a free cash flow of -63.15M.

Operating Cash Flow -62.6M
Capital Expenditures -552K
Free Cash Flow -63.15M
FCF Per Share -4.33
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

JSPR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for JSPR is $64, which is 1409.4% higher than the current price. The consensus rating is "Buy".

Price Target $64
Price Target Difference 1409.4%
Analyst Consensus Buy
Analyst Count 9
Stock Forecasts

Stock Splits

The last stock split was on Jan 4, 2024. It was a backward split with a ratio of 1:10.

Last Split Date Jan 4, 2024
Split Type backward
Split Ratio 1:10

Scores

Altman Z-Score -1.33
Piotroski F-Score 0